Advancements in plant-derived exosome-like vesicles: Versatile bioactive carriers for targeted drug delivery systems

Available online 14 April 2025, 101300

Author links open overlay panel, , , , , Highlights•

Plant-derived exosomes are less likely to cause immune reactions and are biocompatible.

•

Plant-derived exosomes are ideal carriers for drug delivery and gene therapy.

•

Plant-derived exosomes can precisely regulate their loadings to meet different application requirements.

Abstract

Exosomes, small vesicles secreted by a wide range of cells, are found extensively in animals, plants, and microorganisms. Their excellent biocompatibility, efficient delivery capacity, and ease of membrane crossing have drawn significant interest as promising drug delivery carriers. Compared with their animal-derived counterparts, plant-derived exosomes (PDEs), in particular, stand out for their lower toxicity to human tissues, diverse sources, and enhanced targeted delivery capabilities. Advances in both in-depth research and technological development have enabled scholars to isolate exosomes successfully from various plants, exploring their potential in clinical therapies. However, the precise identification of PDEs and their drug delivery mechanisms remains an area of ongoing investigation. This review synthesizes the latest developments in the biogenesis, extraction, separation, and identification of PDEs, along with their engineering modifications and drug-loading strategies. We also delve into the therapeutic applications of exosomes and their future potential in drug delivery, aiming to elucidate the targeted delivery mechanisms of PDEs and pave new paths for clinical drug treatment.

Graphical abstractPlant-derived exosomes, isolated through classical differential centrifugation, exhibit a broad spectrum of physiological activities. Utilizing these exosomes for drug delivery enables precise targeting of lesions, thereby enhancing therapeutic outcomes. By Figdraw.